Author(s):
Mini Dahiya, Sumit Kumar, Monu Yadav, Syed Arman Rabbani, Shiva Tushir, Anjali Dhillon, Kishna Ram Senwar, Aman Sharma
Email(s):
drsumitkumar@cuh.ac.in
DOI:
10.52711/0974-360X.2026.00034
Address:
Mini Dahiya1, Sumit Kumar2*, Monu Yadav3, Syed Arman Rabbani4, Shiva Tushir5, Anjali Dhillon6, Kishna Ram Senwar7, Aman Sharma8
1University Institute of Pharmaceutical Sciences (UIPS), UGC Centre for Advanced Study Panjab University, Chandigarh-160014 (Panjab), India.
2*Department of Pharmaceutical Science, Central University of Haryana, Jant Pali, Mahendragarh, (Haryana)-123031 India.
3,6,7Amity Institute of Pharmacy, Amity University, Haryana, Amity Education Valley, Panchgaon, Manesar, Gurgaon, Haryana, India-122413.
4RAK College of Pharmacy, RAK Medical and Health Sciences University, P.O. Box 11172, Ras Al Khaimah, UAE.
5Department of Pharmacy, Panipat Institute of Engineering and Technology, Samalkha-132102, Panipat, Haryana, Indi.
8Drug Safety Specialist, Parexel International Limited, Chandigarh, India – 160101.
*Corresponding Author
Published In:
Volume - 19,
Issue - 1,
Year - 2026
ABSTRACT:
In the present research work phytochemical analysis of Ferula asafoetida oil and the cytotoxicity study of its PEG-coated chitosan nanoformulation were performed. Total 20 compounds was found in in GC-MS analysis of Ferula asafoetida oils and out of which galbanic acid, ferulic acid, and guaiol was reported to have a therapeutic potential on cancerous cells in literature. Further, 32 factorial design was used to optimize the nanoformulation to attain lowest particle size and maximum entrapment efficiency. The amount of chitosan and PEG were independent factors while dependent factors were particle size and entrapment efficiency. The optimized Ferula asafoetida oil encapsulated nanoformulation (FAOCN) has a particle size of 532.31 nm and 50.81% entrapment efficiency. Moreover, Ferula asafoetida oil and optimized FAOCN has shown significant cytotoxicity property against prostate cancer (PC3), lung cancer (A549) and liver cancer (MIAPACA) cell lines with IC 50 value 28.40 µg/ml, 12.07 µg/ml, 9.72 µg/ml, 9.76 µg/ml and 47.40 µg/ml, 16.63 µg/ml, 13.78 µg/ml, 18.13 µg/ml, respectively. Cytotoxic property of PEG-coated nanoformulations of Ferula asafoetida oil attributed to faster diffusion by better permeation. Ferula asafoetida oil and FAOCN have a promising cytotoxic and anticancer potential against prostate cancer, lung cancer, and liver cancer by owning the presence of therapeutically active compounds which synergistically act via multiple protective mechanisms.
Cite this article:
Mini Dahiya, Sumit Kumar, Monu Yadav, Syed Arman Rabbani, Shiva Tushir, Anjali Dhillon, Kishna Ram Senwar, Aman Sharma. GC–MS analysis of Ferula asafoetida oil and Cytotoxicity and Anticancer Evaluation of its PEG-coated Chitosan Nanoformulation. Research Journal of Pharmacy and Technology. 2026;19(1):241-9. doi: 10.52711/0974-360X.2026.00034
Cite(Electronic):
Mini Dahiya, Sumit Kumar, Monu Yadav, Syed Arman Rabbani, Shiva Tushir, Anjali Dhillon, Kishna Ram Senwar, Aman Sharma. GC–MS analysis of Ferula asafoetida oil and Cytotoxicity and Anticancer Evaluation of its PEG-coated Chitosan Nanoformulation. Research Journal of Pharmacy and Technology. 2026;19(1):241-9. doi: 10.52711/0974-360X.2026.00034 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2026-19-1-34
7. REFERENCES:
1. Loh JS, Tan LKS, Lee WL, Ming LC, How CW, Foo JB, Kifli N, Goh BH, Ong YS. Do Lipid-based Nanoparticles Hold Promise for Advancing the Clinical Translation of Anticancer Alkaloids? Cancers (Basel). 2021; Oct 25; 13(21): 5346. doi: 10.3390/cancers13215346.
2. Mini Dahiya, Monu Yadav, Sumit Kumar, Shilpi Chauhan, Deepak Lamba. GC–MS Analysis and Fabrication of Nanoparticles of Buchanania lanzan oil for the Anticancer activity. Research Journal of Pharmacy and Technology. 2024; 17(10): 4699-6. doi: 10.52711/0974-360X.2024.00724
3. Shore ND. Experience with degarelix in the treatment of prostate cancer. Therapeutic Advances in Urology. 2013; Feb; 5(1): 11-24. doi: 10.1177/1756287212461048.
4. Schalken J, Fitzpatrick JM. Enzalutamide: targeting the androgen signalling pathway in metastatic castration-resistant prostate cancer. BJU International. 2016; Feb; 117(2): 215-25. doi: 10.1111/bju.13123.
5. Slovin SF. Immunotherapy in metastatic prostate cancer. Indian Journal of Urology. 2016; Oct-Dec; 32(4): 271-276. doi: 10.4103/0970-1591.191240.
6. Hema S, Thambiraj S, Shankaran DR. Nanoformulations for Targeted Drug Delivery to Prostate Cancer: An Overview. Journal of Nanoscience and Nanotechnology. 2018; Aug 1; 18(8): 5171-5191. doi: 10.1166/jnn.2018.15420.
7. Zeinab A. Salama, Ahmed M. Aboul-Enein, Alaa A. Gaafar, Mohsen S. Asker, Hanan F. Aly, Habiba A. Ahmed. In-vitro Antioxidant, Antimicrobial and Anticancer Activities of Banana leaves (Musa acuminata) and Olive leaves (Olea europaea L.) as by-products. Research J. Pharm. And Tech. 2020; 13(2): 687-696. doi: 10.5958/0974-360X.2020.00132.8.
8. Fraihat A, Hamdan FR, Abu-Irmaileh B, Abbasi R, Abu-Irmaileh B, Bustanji Y. Evaluation of the antiproliferative Activities of Anthemis bornmuelleri L. and Amygdalis communis L. Extracts Against six Human Cancer cell lines. Research Journal of Pharmacy and Technology. 2018; 11(6): 2512-6. doi:10.5958/0974-360X.2018.00464.X.
9. Zheng Y, You X, Guan S, Huang J, Wang L, Zhang J, Wu J. Poly (Ferulic Acid) with an Anticancer Effect as a Drug Nanocarrier for Enhanced Colon Cancer Therapy. Advanced Functional Materials. 2019; Feb; 29 (15): 1808646. doi: 10.1002/adfm.201808646.
10. Wang P, Jiang F, Chen B, Tang H, Zeng X, Cai D, Zhu M, Long R, Yang D, Kankala RK, Wang S, Liu Y. Bioinspired red blood cell membrane-encapsulated biomimetic nanoconstructs for synergistic and efficacious chemo-photothermal therapy. Colloids and Surfaces B: Biointerfaces. 2020; May; 189: 110842. doi: 10.1016/j.colsurfb.2020.110842.
11. Pool H, Campos-Vega R, Herrera-Hernández MG, García-Solis P, García-Gasca T, Sánchez IC, Luna-Barcenas G, Vergara-Castañeda H. Development of genistein-PEGylated silica hybrid nanomaterials with enhanced antioxidant and antiproliferative properties on HT29 human colon cancer cells. American Journal of Translational Research. 2018; Aug 15; 10 (8): 2306-2323.
12. Morais RP, Novais GB, Sangenito LS, Santos ALS, Priefer R, Morsink M, Mendonça MC, Souto EB, Severino P, Cardoso JC. Naringenin-Functionalized Multi-Walled Carbon Nanotubes: A Potential Approach for Site-Specific Remote-Controlled Anticancer Delivery for the Treatment of Lung Cancer Cells. International Journal of Molecular Sciences. 2020; Jun 26; 21 (12): 4557. doi: 10.3390/ijms21124557.
13. Vafadar A, Shabaninejad Z, Movahedpour A, Fallahi F, Taghavipour M, Ghasemi Y, Akbari M, Shafiee A, Hajighadimi S, Moradizarmehri S, Razi E, Savardashtaki A, Mirzaei H. Quercetin and cancer: new insights into its therapeutic effects on ovarian cancer cells. Cell and Bioscience. 2020; Mar 10; 10:32. doi: 10.1186/s13578-020-00397-0.
14. Shao J, Fang Y, Zhao R, Chen F, Yang M, Jiang J, Chen Z, Yuan X, Jia L. Evolution from small molecule to nano-drug delivery systems: An emerging approach for cancer therapy of ursolic acid. Asian Journal of Pharmaceutical Sciences. 2020; Nov; 15 (6): 685-700. doi: 10.1016/j.ajps.2020.03.001. Epub 2020 Mar 21.
15. Shahabadi N., Akbari A., Karampour F., Falsafi M. Cytotoxicity and antibacterial activities of new chemically synthesized magnetic nanoparticles containing eugenol. Journal of Drug Delivery Science and Technology. 2019; 49: 113–122. doi: 10.1016/j.jddst.2018.11.001.
16. Ali OM, Bekhit AA, Khattab SN, Helmy MW, Abdel-Ghany YS, Teleb M, Elzoghby AO. Synthesis of lactoferrin mesoporous silica nanoparticles for pemetrexed/ellagic acid synergistic breast cancer therapy. Colloids and Surfaces B: Biointerfaces. 2020; Apr; 188: 110824. doi: 10.1016/j.colsurfb.2020.110824.
17. Chac LD, Thinh BB, Yen NT. Anti-cancer activity of dry extract of Anoectochilus setaceus Blume against BT474 breast cancer cell line and A549 lung cancer cell line. Research Journal of Pharmacy and Technology. 2021; 14(2): 730-4. doi:10.5958/0974- 360X.2021.00127.X.
18. Marjaneh RM, Rahmani F, Hassanian SM, Rezaei N, Hashemzehi M, Bahrami A, Ariakia F, Fiuji H, Sahebkar A, Avan A, Khazaei M. Phytosomal curcumin inhibits tumor growth in colitis-associated colorectal cancer. Journal of Cellular Physiology. 2018; Oct; 233 (10): 6785-6798. doi: 10.1002/jcp.26538.
19. Prabhuraj RS, Bomb K, Srivastava R, Bandyopadhyaya R. Dual drug delivery of curcumin and niclosamide using PLGA nanoparticles for improved therapeutic effect on breast cancer cells. Journal of Polymer Research. 2020; May; 27 (5), 133. DOI: 10.1007/s10965-020-02092-7.
20. Ercin E, Kecel-Gunduz S, Gok B, Aydin T, Budama-Kilinc Y, Kartal M. Laurus nobilis L. Essential Oil-Loaded PLGA as a Nanoformulation Candidate for Cancer Treatment. Molecules. 2022; Mar 15; 27 (6): 1899. doi: 10.3390/molecules27061899.
21. Engelberg S, Lin Y, Assaraf YG, Livney YD. Targeted Nanoparticles Harboring Jasmine-Oil-Entrapped Paclitaxel for Elimination of Lung Cancer Cells. International Journal of Molecular Sciences. 2021; Jan 20; 22 (3): 1019. doi: 10.3390/ijms22031019.
22. Panyajai P, Chueahongthong F, Viriyaadhammaa N, Nirachonkul W, Tima S, Chiampanichayakul S, Anuchapreeda S, Okonogi S. Anticancer activity of Zingiber ottensii essential oil and its nanoformulations. PLoS One. 2022; Jan 24; 17(1): e0262335. doi: 10.1371/journal.pone.0262335.
23. Sharifi-Rad J, Quispe C, Mukazhanova Z, Knut E, Turgumbayeva A, Kipchakbayeva A, Seitimova G, Mahomoodally MF, Lobine D, Koay A, Wang J, Sheridan H, Leyva-Gomez G, Prado-Audelo MLD, Cortes H, Rescigno A, Zucca P, Sytar O, Imran M, Rodrigues CF, Cruz-Martins N, Ekiert H, Kumar M, Abdull Razis AF, Sunusi U, Kamal RM, Szopa A. Resveratrol-Based Nanoformulations as an Emerging Therapeutic Strategy for Cancer. Frontiers in Molecular Biosciences. 2021; Sep 1; 8: 649395. doi: 10.3389/fmolb.2021.649395.
24. Sindhu Priya. S, B. Ramamurthy. Lung Cancer Detection using Image Processing Technique. Research J. Pharm. and Tech. 2018; 11(5): 2045-2049. doi: 10.5958/0974-360X.2018.00379.7.
25. Kanauchi, Osamu, Keiji Deuchi, Youji Imasato and Eiichi Kobayashi. “Increasing Effect of a Chitosan and Ascorbic Acid Mixture on Fecal Dietary Fat Excretion.” Bioscience, Biotechnology, and Biochemistry 58 (1994): 1617-1620.
26. Adhikari M., Kharel N., Gaire L., Poudel R., Shrestha S.M., Gaire S.P., and Acharya B 2018, In vitro evaluation of different chemicals against Rhizoctonia solani by poisoned food technique Field Cr op, 1(2): 5-8 (doi: 10.5376/fc.2018.01.0002).
27. Yadav M, Parle M, Sharma N, Dhingra S, Raina N, Jindal DK. Brain targeted oral delivery of doxycycline hydrochloride encapsulated Tween 80 coated chitosan nanoparticles against ketamine induced psychosis: behavioral, biochemical, neurochemical and histological alterations in mice. Drug Delivery. 2017; Nov; 24(1): 1429-1440. doi: 10.1080/10717544.2017.1377315.
28. Punna Venkateshwarlu, Mehul M. Patel. A Review: Method Development Validation and Degradation Studies of some Anticancer Drugs. Research Journal of Pharmacy and Technology. 2021; 14(10): 5443-8. doi: 10.52711/0974-360X.2021.00949.